KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationAmortization - Deferred ChargesCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Repligen (RGEN) Shares Repurchased (2011)

Repligen (RGEN) reported Shares Repurchased of $419267.0 for Q3 2011, up 374.28% on a QoQ basis from $88401.0 in Q2 2011.

Repligen (RGEN) has 1 years of Shares Repurchased data on file, last reported at $419267.0 in Q3 2011.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Repurchased (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn 1.12 Bn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn 2.00 Bn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn 175.01 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn 297.60 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn 67.00 Mn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn 92.50 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn 31.20 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn -
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn 99.97 Mn
10 Repligen 6.39 Bn 5.41 Bn 108.28 Mn -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2011 419,267.00
Sep 30, 2011 419,267.00
Jun 30, 2011 88,401.00
Jun 30, 2011 88,401.00
Mar 31, 2011 88,401.00
Mar 31, 2011 88,401.00